Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

2020822 citationslettergreen Open Access

Authors

Alicia T. Widge · National Institute of Allergy and Infectious Diseases

Nadine Rouphael · Emory University

Lisa A. Jackson · Kaiser Permanente Washington Health Research Institute

Evan J. Anderson · Emory University

Paul C. Roberts · ActionAid

Mamodikoe Makhene · ActionAid

James D. Chappell

Abstract

Immunogenicity and the mRNA-1273 SARS-CoV-2 Vaccine Thirty-four adults received two 100-μg injections of the mRNA-1273 SARS-CoV-2 vaccine, and serum anti–spike protein and neutralizing antibody tit...

Topics & Keywords

SARS-CoV-2 and COVID-19 Research Animal Virus Infections Studies Immunotherapy and Immune Responses

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 384, Issue 1, pp. 80-82

DOI: 10.1056/nejmc2032195

Field-Weighted Citation Impact: 19.45